The Potential of Interferons in Malignant Disease
- 1 January 1990
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 39 (1), 1-6
- https://doi.org/10.2165/00003495-199039010-00001
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- PHASE-II STUDY OF BETASERON (BETA-SER17-INTERFERON) AS TREATMENT OF ADVANCED MALIGNANT-MELANOMA1987
- Phase II study of recombinant alfa-2a interferon in patients with advanced bone sarcomas.1987
- Saturation index of blood cell membrane fatty acids before and after IFN treatment in hairy cell leukemia.1987
- Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma.Journal of Clinical Oncology, 1985
- HUMAN-LEUKOCYTE INTERFERON AND INTERMITTENT HIGH-DOSE MELPHALAN-PREDNISONE ADMINISTRATION IN THE TREATMENT OF MULTIPLE-MYELOMA - A RANDOMIZED CLINICAL-TRIAL FROM THE MYELOMA GROUP OF CENTRAL SWEDEN1984
- INDUCTION OF MOUSE IGG2A-DEPENDENT AND IGG3-DEPENDENT CELLULAR CYTO-TOXICITY IN HUMAN MONOCYTIC CELLS (U937) BY IMMUNE INTERFERON1984
- How does interferon inhibit tumour growth?Philosophical Transactions of the Royal Society of London. B, Biological Sciences, 1982
- The effects of interferon on the fatty acids in uninfected cellsFEBS Letters, 1981
- Interferon-neutralizing antibodies in a patient treated with human fibroblast interferonNature, 1981
- Virus interference. I. The interferonProceedings of the Royal Society of London. B. Biological Sciences, 1957